GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mymetics Corp (OTCPK:MYMX) » Definitions » Shiller PE Ratio

Mymetics (Mymetics) Shiller PE Ratio : (As of May. 28, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Mymetics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mymetics Shiller PE Ratio Historical Data

The historical data trend for Mymetics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mymetics Shiller PE Ratio Chart

Mymetics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mymetics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mymetics's Shiller PE Ratio

For the Biotechnology subindustry, Mymetics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mymetics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mymetics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mymetics's Shiller PE Ratio falls into.



Mymetics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mymetics's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, Mymetics's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-7.828/106.5695*106.5695
=-7.828

Current CPI (Sep. 2023) = 106.5695.

Mymetics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 27.397 101.036 28.898
201403 -8.426 101.224 -8.871
201406 -7.289 101.517 -7.652
201409 -7.255 101.247 -7.636
201412 -5.513 100.704 -5.834
201503 -6.791 100.339 -7.213
201506 -4.160 100.464 -4.413
201509 -5.838 99.785 -6.235
201512 0.000 99.386 0.000
201603 -4.348 99.475 -4.658
201606 -6.836 100.088 -7.279
201609 -7.412 99.604 -7.930
201612 -21.097 99.380 -22.623
201703 -8.725 100.040 -9.294
201706 -5.711 100.285 -6.069
201709 -8.005 100.254 -8.509
201712 0.000 100.213 0.000
201803 -7.291 100.836 -7.706
201806 -8.707 101.435 -9.148
201809 -8.228 101.246 -8.661
201812 0.000 100.906 0.000
201903 -9.136 101.571 -9.586
201906 -7.306 102.044 -7.630
201909 -7.933 101.396 -8.338
201912 0.000 101.063 0.000
202003 -8.469 101.048 -8.932
202006 -7.645 100.743 -8.087
202009 -8.050 100.585 -8.529
202012 0.000 100.241 0.000
202103 -9.767 100.800 -10.326
202106 -8.742 101.352 -9.192
202109 -8.931 101.533 -9.374
202112 -22.599 101.776 -23.663
202203 -8.781 103.205 -9.067
202206 -9.340 104.783 -9.499
202209 -8.768 104.835 -8.913
202212 -21.186 104.666 -21.571
202303 -13.119 106.245 -13.159
202306 -54.821 106.576 -54.818
202309 -7.828 106.570 -7.828

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mymetics  (OTCPK:MYMX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mymetics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mymetics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mymetics (Mymetics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Mymetics SA, Route de la Corniche 4, Biopole Center, Epalinges, CHE, CH-1066
Mymetics Corp is a vaccine company and is focused on the research and development of next-generation vaccines for infectious and life-disabling diseases. Its vaccine candidates in the pipeline include HIV-1/AIDS, malaria, and Covid-19, and intranasal influenza, RSV, Chikungunyaand HSV vaccine candidate programs.
Executives
Marcel B. Ruegg director C/O MYMETICS CORPORATION, ROUTE DE LA CORNICHE 4 1066, EPALINGES V8 NA
Kempers Ronald Hugo Gerard officer: President, CEO, CFO ES GRANDS CHAMPS 12, DULLY V8 1195
Christopher S Henney director 10505 ROSELLE STREET, SAN DIEGO CA 92121
Grant Pickering director, officer: President and CEO C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070
Ulrich Burkhard director C/O MYMETICS CORPORATION, ROUTE DE LA CORNICHE 4 1066, EPALINGES V8 NA
Jacques Francois Martin officer: CEO 40 QUAI FULCHIRON, LYON I0 69005
Antonius Johannes Stegmann officer: CSO KONINGIN EMMAPLANTSOEN 6, RIJNSBURG P7 2231TZ
Ernest M Stern director 815 CONNECTICUT AVE, NW, SUITE 500, SEYFARTH SHAW LLP, WASHINGTON DC 20006
Thomas Staehelin director POSTFACH 2879, FROMER, SCHULTHEISS & STAEHELIN, BASEL V8 CH-4002
Sylvain Fleury officer: CSO CHEMIN DE VERDONNET 9, LAUSANNE V8 1010
Round Enterprises, Ltd. 10 percent owner C/O BACHMANN TRUST COMPANY LIMITED, FRANCES HOUSE, SIR WILLIAM PLACE, ST. PETER PORT X0 GY1 4EA
Mfc Bancorp Ltd 10 percent owner ROOM 2103 SHANGHAI MART TOWER, 2299 YAN AN ROAD WEST, CHANGNING DISTRICT, SHANGHAI F4 200336
Christian Rochet director, officer: CEO 14, RUE DE LA COLOMBIERE, NYON V8 1260
Robert Zimmer director, officer: vp corp development
Ernst Lubke director, officer: CFO 39, ROUTE D'ARZIER, ARZIER V8 CH-1273